Literature DB >> 22088760

A double-targeted magnetic nanocarrier with potential application in hydrophobic drug delivery.

Guobin Ding1, Yi Guo, Yanyun Lv, Xiaofeng Liu, Li Xu, Xuezhong Zhang.   

Abstract

A double-targeted magnetic nanocarrier based with potential applications in the delivery of hydrophobic drugs has been developed. It consists of magnetite (Fe(3)O(4)) nanoparticles encapsulated in self-assembled micelles of the amphiphilic copolymer MPEG-PLGA [methoxy poly (ethylene glycol)-poly (d,l-lactide-co-glycolide)], and was fabricated using the solvent-evaporation technique. The magnetic nanocarrier has a very stable core-shell structure and is superparamagnetic. Its cytotoxicity was evaluated using the MTT assay with three cell lines-HeLa, MCF-7, and HT1080; it exhibited no cytotoxicity against any tested line at concentrations of up to 400 μg/mL after incubation for 24 h. Its cellular uptake was studied by Prussian blue staining and by fluorescence microscopy after encapsulating a fluorescent probe (hydrophobic quantum dots) into the nanocarrier. Finally, the magnetic targeting property of the magnetic nanocarrier was confirmed by an in vitro test. Overall, the results obtained demonstrate the potential of the double-targeted nanocarrier for the intracellular delivery of hydrophobic drugs.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22088760     DOI: 10.1016/j.colsurfb.2011.10.036

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  2 in total

1.  Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery.

Authors:  Iva Blazkova; Hoai Viet Nguyen; Simona Dostalova; Pavel Kopel; Maja Stanisavljevic; Marketa Vaculovicova; Marie Stiborova; Tomas Eckschlager; Rene Kizek; Vojtech Adam
Journal:  Int J Mol Sci       Date:  2013-06-27       Impact factor: 5.923

2.  Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy.

Authors:  Zhuoran Wang; Yue Zhao; Shuai Zhang; Xuehui Chen; Guoming Sun; Baoli Zhang; Bing Jiang; Yili Yang; Xiyun Yan; Kelong Fan
Journal:  Theranostics       Date:  2022-01-24       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.